Incidence of Macular Edema in a Uveitis Population

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

1550 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-01

Study Completion Date

2025-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Macular edema from uveitis is a serious condition that can lead to vision loss. Uveitis is an inflammation inside the eye, and macular edema is when fluid builds up in the central part of the retina, called the macula, which is crucial for clear vision. This fluid buildup can blur vision, sometimes severely. Managing this condition can be challenging and may require several treatments to reduce the fluid and protect sight. While we know macular edema is a common cause of vision loss in uveitis, there's limited data on how often it affects people in Europe

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate

NCT01314417

Non-infectious Intermediate and Posterior Uveitis

TERMINATED PHASE1/PHASE2

Biomarkers in Ocular Inflammation and Uveitis

NCT04690829

Uveitis Ocular Inflammation

COMPLETED

Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study

NCT02651168

Diabetic Macular Edema

UNKNOWN PHASE4

Evaluation and Treatment of Patients With Inflammatory Eye Diseases

NCT00006188

Choroiditis Iridocyclitis Iritis +1 more

COMPLETED

The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma

NCT00943982

Uveitis

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Macular Edema Non-infectious Uveitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non-infectious uveitis patients treated at a hospitals in the North Denmark Region

Local and systemical treatment

Intervention Type DRUG

Evaluating the management of the edema including topical/local treatment (dexamethasone and NSAID, periocular injections, and dexamethasone intravitreal implant) and systemic treatment (prednisolone, DMARD, and biological agents, for example TNF-alpha inhibitors and interleukin-6 inhibitors). Moreover, the duration of any treatment as well as numbers of injections or implants.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Local and systemical treatment

Evaluating the management of the edema including topical/local treatment (dexamethasone and NSAID, periocular injections, and dexamethasone intravitreal implant) and systemic treatment (prednisolone, DMARD, and biological agents, for example TNF-alpha inhibitors and interleukin-6 inhibitors). Moreover, the duration of any treatment as well as numbers of injections or implants.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hospital-admitted patients in the North Denmark Region with non-infectious uveitis.
* Both juvenile and adult patients.
* Diagnosed with non-infectious uveitis by a medical doctor.
* Patients presenting with unspecific macular edema may be included if medical records indicate uveitis as the cause of the edema.

Exclusion Criteria

* Patients incorrectly classified as having uveitis based on their medical records (no confirmed diagnosis of uveitis).
* Patients with infectious uveitis.
* Macular edema due to other cause than uveitis will not count as uveitis associated edema

Eligible Sex

ALL

Accepts Healthy Volunteers

No